Isofol appoints Roger Tell as Chief Medical Officer ahead of initiation of clinical study
GOTHENBURG, Sweden, February 3, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that Roger Tell has been appointed Chief Medical Officer at Isofol ahead of the initiation of the planned clinical study. The information in the press release is intended for investors. Dr. Roger Tell (MD, PhD) has been active at Isofol […]